KCTD7 and Progressive myoclonic epilepsy: Mutations in CLN14/KCTD7 cause three different diseases (16, 44–46) classed as progressive myoclonic epilepsy (PME) (47, 48), and in rarer cases PME accompanied by vision loss and lysosomal storage and termed an NCL (16, 49).